PIMREG and adrenal cortex carcinoma: In addition, KM plotter results showed that among the individuals with ACC (Figure 3B, p = 0.043), BRCA (Figure 3C, p = 0.033), CHOL (Figure 3D, p = 0.006), KIRC (Figure 3E, p < 0.001), LGG (Figure 3F, p < 0.001), LUAD (Figure 3G, p = 0.004), MESO (Figure 3H, p < 0.001), PAAD (Figure 3I, p = 0.014), PRAD (Figure 3J, p = 0.028), and SARC (Figure 3K, p = 0.011), those with high PIMREG expression had less time of survival, while the individuals with TYHM (Figure 3L, p = 0.033) had a longer survival time.